Find A Clinical Trial

Disease Type: Head and Neck

Trial ID M21-410
Sponsor ID AbbVie

A Global First-in-Human Study in NSCLC, HNSCC and Solid Tumors with ABBV-514 as a Single Agent and in Combination with Pembrolizumab or Budigalimab

Trial ID VX15-2503-12
Sponsor ID KEYNOTE 84

A Phase 1b/2 Study of the Combination of Pepinemab and Pembrolizumab in Patients with Advanced, Recurrent, or Metastatic Squamous Cell Cancer of the Head and Neck